EyeWorld Korea December 2019 Issue

Continuous innovations in surgical techniques and enhancement in technologies has enabled the ophthalmic community to provide better surgical outcomes and more options for cataract patients. The Alcon’s FORESIGHT 2019 meeting, which was held on June 22- 23, 2019 in Hong Kong, attracted experts and key opinion leaders from the Asia- 3DFLȴF UHJLRQZKR VKRZFDVHG WKH UHFHQW DGYDQFHV LQ WHFKQLTXHV DQG WHFKQRORJLHV DQG VKDUHG FOLQLFDO H[SHULHQFH DQG insight on the latest developments in cataract surgery. Themajor areas of discussion and interest included advanced WHFKQRORJ\ LQWUDRFXODU OHQVHV LQQRYDWLYH SKDFRHPXOVLȴFDWLRQ WHFKQLTXHV FDWDUDFW UHIUDFWLYH VXLWHV DQG WKUHH dimensionalcataractsurgery.Themeetinginspiredideasanddiscussionswiththevisiontohelppatientsseebrilliantly. TECHNOLOGICAL ADVANCES IN CATARACT SURGERY INNOVATION AND EVOLUTION IN CATARACT SURGERY: PAST, PRESENT AND FUTURE Technological innovation and technique evolution in ophthalmology over the past 20 years, has led to a remarkable transformation in the techniques and success of cataract surgeries, highlighted Dr Ronald Yeoh, Adjunct Associate Professor, Singapore National Eye Centre. Cataract surgery has evolved from couching, intra-capsular cataract HPXOVLȴFDWLRQ Ζ&&( H[WUD FDSVXODU FDWDUDFW HPXOVLȴFDWLRQ (&&( DQG VPDOO LQFLVLRQ FDWDUDFW VXUJHU\ 6Ζ&6 WR SKDFRHPXOVLȴFDWLRQ SKDFR FDWDUDFW VXUJHU\ DQG PRUH UHFHQWO\ WR IHPWRVHFRQG ODVHU DVVLVWHG FDWDUDFW VXUJHU\ )/$&6 7KH LQWURGXFWLRQ RI IROGDEOH LQWUDRFXODU OHQVHV Ζ2/V LQ SKDFR FDWDUDFW VXUJHU\ OHG WR VPDOOHU LQFLVLRQV DQG EHWWHU UHIUDFWLYH UHVXOWV )XUWKHU DGYDQFHV LQ Ζ2/ GHYHORSPHQW LQFOXGH DVSKHULFLW\ WRULFLW\ EL IRFDOLW\ WUL IRFDOLW\ DQG DGMXVWDEOH Ζ2/V SURYLGLQJ WKH SDWLHQWV DQG VXUJHRQV with more options and better outcomes. Newer research on non- GL΍UDFWLYH Ζ2/V DORQJ ZLWK DFFRPPRGDWLQJ DGMXVWDEOH DQG PRGXODU Ζ2/V VHHPV SURPLVLQJ LQ RXU TXHVW IRU WRWDO VSHFWDFOH IUHHGRP )XUWKHU H[FLWLQJ GHYHORSPHQWV LQ FDWDUDFW VXUJHU\ LQFOXGH WKH FDWDUDFW UHIUDFWLYH VXLWHV DQG WKUHH GLPHQVLRQDO ' VXUJHU\ 7KH QHZ 1*(18Ζ7< ® ' 9LVXDOL]DWLRQ 6\VWHP SURYLGHV UHDO WLPH GDWD RQ RQH VFUHHQ ZKLOH DOORZLQJ WKUHH GLPHQVLRQDO YLVXDOL]DWLRQ WKHUHE\ enhancing surgical performance. The cataract refractive suite also presents a new standard of performance in cataract surgery that LQWHJUDWHV GL΍HUHQW WHFKQRORJLHV DQG GHYLFHV WR LPSURYH VDIHW\ HɝFDF\ DQG SUHFLVLRQ RI FDWDUDFW VXUJHU\ Ȋ:LWK VXUJH LQ GHYHORSPHQW RI URERWV DUWLȴFLDO LQWHOOLJHQFH and machine learning, the use of healthcare data and speed of LPSOHPHQWDWLRQ RI QHZ WHFKQRORJLHV LV FKDQJLQJ H[SRQHQWLDOO\ 7KH healthcare community will need to catch up with these technologies WR VWD\ DEUHDVW ZLWK WKH IXWXUH RI KHDOWKFDUH ȋ UHPDUNHG 0U /XFLHQ Engelen, Global Strategist Digital Health for Deloitte’s Center for the Edge, Netherlands. “Alcon is designing applications to assist patient’s journey by VLPSOLI\LQJ WKH FRPSOH[LW\ RI VXUJHU\ DQG DGGLQJ HɝFLHQF\ WR SUDFWLFH 6HDPOHVV GDWD H[FKDQJH DQG FORXG EDVHG GHFLVLRQ VXSSRUW WKURXJK DUWLȴFLDO LQWHOOLJHQFH DQG PDFKLQH OHDUQLQJ ZLOO DGGUHVV WKH technology gaps in cataract patients’ refractive journey”, highlighted /X[LQ :DQJ $OFRQ $VLD 6XUJLFDO )UDQFKLVH +HDG Ȋ:LWK VXUJH LQ GHYHORSPHQW RI URERWV DUWLȴFLDO LQWHOOLJHQFH DQG PDFKLQH OHDUQLQJ WKH XVH RI KHDOWKFDUH GDWD DQG VSHHG RI LPSOHPHQWDWLRQ RI QHZ WHFKQRORJLHV LV FKDQJLQJ H[SRQHQWLDOO\ ȋ 0U /XFLHQ (QJHOHQ Ȋ0HUHO\ LQYHQWLQJ D QHZ WHFKQRORJ\ LV QRW HQRXJK LW KDV WR EH DFFRPSDQLHG E\ PRGLȴFDWLRQ RI VXUJLFDO WHFKQLTXHV :H QHHG FRQYHUJHQFH RI WHFKQRORJ\ DQG WHFKQLTXH ȋ 'U 5RQDOG <HRK ůĐŽŶ ŝƐ ĐŽŵŵŝƚĞĚ ƚŽ ĚĞƐŝŐŶ ĂƉƉůŝĐĂƟŽŶƐ ĂŶĚ ĂĚĚƌĞƐƐ ƚĞĐŚŶŽůŽŐŝĐĂů ŐĂƉƐ ŝŶ ƚŚĞ ĐĂƚĂƌĂĐƚ ƌĞĨƌĂĐƟǀĞ ƉĂƟĞŶƚ ũŽƵƌŶĞLJ Ȋ$OFRQ LV GHVLJQLQJ DSSOLFDWLRQV WR DVVLVW SDWLHQWȇV MRXUQH\ E\ VLPSOLI\LQJ WKH FRPSOH[LW\ RI VXUJHU\ DQG DGGLQJ HɝFLHQF\ WR SUDFWLFH ȋ /X[LQ :DQJ